Categoría: Heart Failure
-
Cord Blood Cells Make New Blood Vessels
A paper published today from the Mary Laughlin’s group describes the use of cord blood cells in creation of new blood vessels.
-
NOXXON Announces Initiation of First-in-Human Clinical Trial with Hematopoietic Stem Cell Mobilizing Spiegelmer® NOX-A12
Today NOXXON announced that is has successfully administered its NOX-A12 aptamer-based mobilizer to healthy volunteers as part of a Phase I clinical trial.
-
Use of Frozen Stem Cells Successful in Heart Failure
In a recent paper the use of mesenchymal stem cells was evaluated after the cells have been stored frozen.
-
Stem cell therapy maker Aldagen files for IPO
The adult stem cell company Aldagen Inc, from Durham North Carolina announced today that it has filed a registration with the Securities Exchange Commission for an initial public offering with a potential value of $80.5 million.
-
Fat-Derived Adult Stem Cells Targeted for Heart Disease Therapy
In yet another heart disease study, adult stem cells derived from adipose tissue are chosen as the most promising therapy.
-
Adult Stem Cells Used in Clinical Trial for Heart Failure
The U.S. adult stem cell company Bioheart has announced positive results from its clinical trial in the treatment of heart failure with adult stem cells.
-
Stem Cell Pioneers Honored at Lasker Awards
Among this year’s recipients of the Lasker Awards are Dr. Shinya Yamanaka of Kyoto University in Japan and Dr. John Gurdon of Cambridge University in England.
-
Neuralstem Awarded Adult Stem Cell Patent
The U.S. company Neuralstem receives yet another patent for its novel adult stem cell technology.
-
Adult Stem Cell Company Reports on Heart Therapy
The adult stem cell company Cardio3 BioSciences presents an update on its heart failure therapy at the annual conference of the European Society of Cardiology.
-
Adult Stem Cells Treat Heart Failure
Doctors in Houston use autologous adult stem cell therapy to treat heart failure in an FDA-approved clinical trial.